EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseVergleichsstudie

Comparative Effectiveness and Safety of Fecal Microbiota Transplantation in Ulcerative Colitis: An Updated Systematic Review and Meta-Analysis

Bin Huang, Honglin An, Yiman Qiu, Tingting Ye, Yuqing Huang, Mingxuan Zheng, Dan Shi, Yanqing Su, Rong Wang

Advances in Therapy · 2026-06 · 43 (6) · 2645-2667

DOI: 10.1007/s12325-025-03431-0 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Advances in Therapy, online erschienen am 07.04.2026. Verfasst von Bin Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Integrative Medicine, Fujian Key Laboratory of Integrative Medicine on Geriatrics, Key Laboratory of Integrative Medicine of Fujian Provin…. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Colitis, Ulcerative. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Young Talent Supporting Program of the China Association of Chinese Medicine (CACM), Financial Project of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Fecal microbiota transplantation (FMT) is a potential therapy for ulcerative colitis (UC). Evidence has expanded, but the impact of delivery route on efficacy and safety remains uncertain. METHODS: We systematically searched PubMed, Embase, Cochrane Library, Web of Science and China National Knowledge Infrastructure (CNKI) from inception to October 2025 for randomized controlled trials (RCTs) comparing donor-derived FMT with placebo/sham or autologous FMT in patients with UC. Primary outcomes were clinical and endoscopic remission at induction (8-12 weeks). Adverse events (AEs) were secondary. Random effect models generated risk ratios (RRs) with 95% CIs. Pre-specified subgroup analyses compared delivery routes (colonoscopy, rectal enema, combined colonoscopy + enema, nasoduodenal infusion, oral capsules). RESULTS: Sixteen RCTs were included. Overall, FMT improved clinical remission (RR = 1.81, 95% CI: 1.41-2.31; I2 = 0%) and endoscopic remission (RR = 1.74, 95% CI: 1.00-3.01; I2 = 45.5%). By route, significant effects were seen for colonoscopy (RR = 1.58, 95% CI 1.05-2.37), rectal enema (RR = 1.62, 95% CI 1.04-2.54) and combined colonoscopy + enema (RR = 2.39, 95% CI 1.47-3.89) for clinical remission; nasoduodenal and oral capsule results were imprecise. For endoscopic remission, the combined route showed the most consistent benefit (RR = 2.19, 95% CI 1.04-4.62). AEs did not differ from control (RR = 1.03, 95% CI 0.90-1.18; I2 = 11.2%). CONCLUSIONS: FMT improves induction-phase clinical and endoscopic remission in patients with UC without increasing AEs. Efficacy appears route-dependent, with colonoscopy + enema demonstrating the largest effect. Head-to-head trials optimizing route and dosing with longer follow-up are warranted. Ulcerative colitis is a chronic condition that causes inflammation in the colon and rectum, leading to symptoms like abdominal pain, diarrhea and bleeding. While current medications help many patients, some do not respond well or experience side effects. Fecal microbiota transplantation (FMT) is a treatment that involves transferring beneficial bacteria from a healthy donor to restore balance in the gut. This study combined 16 randomized trials to evaluate the effectiveness and safety of FMT for ulcerative colitis. Overall, patients who received FMT were more likely to achieve remission compared to those receiving a placebo or their own stool. The best results were observed when FMT was delivered via colonoscopy followed by enemas. Other methods, such as capsules or upper gut delivery, showed uncertain effects because of the small number of trials available. Importantly, the side effect rates were similar between the FMT and control groups, indicating that FMT is generally safe in the short term. These findings suggest that FMT can help some patients with ulcerative colitis achieve remission, especially with colonoscopy and enemas, but further long-term studies are needed to confirm the durability of the benefits and identify the most effective delivery methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fecal Microbiota TransplantationColitis, UlcerativeHumansRandomized Controlled Trials as TopicEnemaRemission InductionTreatment OutcomeColonoscopy

Stichwörter der Autor:innen

Delivery routeFecal microbiota transplantationMeta-analysisRandomized controlled trialUlcerative colitis

Autor:innen und Institutionen

  • Academy of Integrative Medicine, Fujian Key Laboratory of Integrative Medicine on Geriatrics, Key Laboratory of Integrative Medicine of Fujian Province University, Fujian University of Traditional Chinese Medicine, Fuzh…
  • The Affiliated People's Hospital, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, 350004, People's Republic of China. 1196096001@qq.com.
  • The Affiliated People's Hospital, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, 350004, People's Republic of China.
  • Fujian Maternity and Child Health Hospital, Fuzhou, Fujian, 350001, People's Republic of China.
  • Department of Pharmacy, Xiamen Children's Hospital, Xiamen, 361006, Fujian, China. suyanqing910125@163.com.
  • The Affiliated People's Hospital, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, 350004, People's Republic of China. ronglittle2003@163.com.

Förderung

  • National Natural Science Foundation of China
  • Young Talent Supporting Program of the China Association of Chinese Medicine (CACM)
  • Financial Project of Fujian Province
  • Natural Science Foundation of Fujian Province, China
  • Fujian Provincial Science and Technology Project in Traditional Chinese Medicine

Zitieren

APA

Huang, B., An, H., Qiu, Y., Ye, T., Huang, Y., Zheng, M., Shi, D., Su, Y., & Wang, R. (2026). Comparative Effectiveness and Safety of Fecal Microbiota Transplantation in Ulcerative Colitis: An Updated Systematic Review and Meta-Analysis. Advances in Therapy, 43(6), 2645-2667. https://doi.org/10.1007/s12325-025-03431-0

Vancouver

Huang B, An H, Qiu Y, Ye T, Huang Y, Zheng M, et al. Comparative Effectiveness and Safety of Fecal Microbiota Transplantation in Ulcerative Colitis: An Updated Systematic Review and Meta-Analysis. Advances in Therapy. 2026;43(6):2645-2667. doi:10.1007/s12325-025-03431-0

BibTeX
@article{Huang2026,
  author = {Huang, Bin and An, Honglin and Qiu, Yiman and Ye, Tingting and Huang, Yuqing and Zheng, Mingxuan and Shi, Dan and Su, Yanqing and Wang, Rong},
  title = {Comparative Effectiveness and Safety of Fecal Microbiota Transplantation in Ulcerative Colitis: An Updated Systematic Review and Meta-Analysis},
  journal = {Advances in Therapy},
  year = {2026},
  volume = {43},
  number = {6},
  pages = {2645--2667},
  doi = {10.1007/s12325-025-03431-0}
}
Kostenlos starten →